Patents by Inventor Alexander Filatenkov

Alexander Filatenkov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TUMOR VACCINATION IN COMBINATION WITH HEMATOPOIETIC CELL TRANSPLANTATION FOR CANCER THERAPY
    Publication number: 20230248812
    Abstract: In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation. In another aspect, the present invention provides a method of purifying tumor cells from a subject in preparation for vaccination.
    Type: Application
    Filed: April 7, 2023
    Publication date: August 10, 2023
    Inventors: Samuel Strober, Alexander Filatenkov
  • Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
    Patent number: 11648301
    Abstract: In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation. In another aspect, the present invention provides a method of purifying tumor cells from a subject in preparation for vaccination.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: May 16, 2023
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Samuel Strober, Alexander Filatenkov
  • ANTI-TUMOR T CELL IMMUNITY INDUCED BY HIGH DOSE RADIATION
    Publication number: 20220008468
    Abstract: Cancer treatment is provided, by irradiating an individual with a localized, high single dose or short course of doses at a primary tumor site; collecting T cells from the individual after a period of time sufficient activation of an anti-tumor response; treating the individual with an effective dose of dose of chemotherapy; and reintroducing the T cell population back to the individual.
    Type: Application
    Filed: June 24, 2021
    Publication date: January 13, 2022
    Inventors: Samuel Strober, Alexander Filatenkov
  • Anti-tumor T cell immunity induced by high dose radiation
    Patent number: 11077141
    Abstract: Cancer treatment is provided, by irradiating an individual with a localized, high single dose or short course of doses at a primary tumor site; collecting T cells from the individual after a period of time sufficient activation of an anti-tumor response; treating the individual with an effective dose of dose of chemotherapy; and reintroducing the T cell population back to the individual.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: August 3, 2021
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Samuel Strober, Alexander Filatenkov
  • TUMOR VACCINATION IN COMBINATION WITH HEMATOPOIETIC CELL TRANSPLANTATION FOR CANCER THERAPY
    Publication number: 20190201514
    Abstract: In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation. In another aspect, the present invention provides a method of purifying tumor cells from a subject in preparation for vaccination.
    Type: Application
    Filed: March 21, 2019
    Publication date: July 4, 2019
    Inventors: Samuel Strober, Alexander Filatenkov
  • Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
    Patent number: 10286049
    Abstract: In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation. In another aspect, the present invention provides a method of purifying tumor cells from a subject in preparation for vaccination.
    Type: Grant
    Filed: November 9, 2015
    Date of Patent: May 14, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Samuel Strober, Alexander Filatenkov
  • ANTI-TUMOR T CELL IMMUNITY INDUCED BY HIGH DOSE RADIATION
    Publication number: 20190083537
    Abstract: Cancer treatment is provided, by irradiating an individual with a localized, high single dose or short course of doses at a primary tumor site; collecting T cells from the individual after a period of time sufficient activation of an anti-tumor response; treating the individual with an effective dose of dose of chemotherapy; and reintroducing the T cell population back to the individual.
    Type: Application
    Filed: November 28, 2018
    Publication date: March 21, 2019
    Inventors: Samuel Strober, Alexander Filatenkov
  • Anti-tumor T cell immunity induced by high dose radiation
    Patent number: 10166256
    Abstract: Cancer treatment is provided, by irradiating an individual with a localized, high single dose or short course of doses at a primary tumor site; collecting T cells from the individual after a period of time sufficient activation of an anti-tumor response; treating the individual with an effective dose of dose of chemotherapy; and reintroducing the T cell population back to the individual.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: January 1, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Samuel Strober, Alexander Filatenkov
  • ANTI-TUMOR T CELL IMMUNITY INDUCED BY HIGH DOSE RADIATION
    Publication number: 20170119821
    Abstract: Cancer treatment is provided, by irradiating an individual with a localized, high single dose or short course of doses at a primary tumor site; collecting T cells from the individual after a period of time sufficient activation of an anti-tumor response; treating the individual with an effective dose of dose of chemotherapy; and reintroducing the T cell population back to the individual.
    Type: Application
    Filed: November 8, 2016
    Publication date: May 4, 2017
    Inventors: Samuel Strober, Alexander Filatenkov
  • Anti-tumor T cell immunity induced by high dose radiation
    Patent number: 9545444
    Abstract: Cancer treatment is provided, by irradiating an individual with a localized, high single dose or short course of doses at a primary tumor site; collecting T cells from the individual after a period of time sufficient activation of an anti-tumor response; treating the individual with an effective dose of dose of chemotherapy; and reintroducing the T cell population back to the individual.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: January 17, 2017
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Samuel Strober, Alexander Filatenkov
  • TUMOR VACCINATION IN COMBINATION WITH HEMATOPOIETIC CELL TRANSPLANTATION FOR CANCER THERAPY
    Publication number: 20160051653
    Abstract: In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation. In another aspect, the present invention provides a method of purifying tumor cells from a subject in preparation for vaccination.
    Type: Application
    Filed: November 9, 2015
    Publication date: February 25, 2016
    Inventors: Samuel Strober, Alexander Filatenkov
  • ANTI-TUMOR T CELL IMMUNITY INDUCED BY HIGH DOSE RADIATION
    Publication number: 20150366964
    Abstract: Cancer treatment is provided, by irradiating an individual with a localized, high single dose or short course of doses at a primary tumor site; collecting T cells from the individual after a period of time sufficient activation of an anti-tumor response; treating the individual with an effective dose of dose of chemotherapy; and reintroducing the T cell population back to the individual.
    Type: Application
    Filed: June 25, 2015
    Publication date: December 24, 2015
    Inventors: Samuel Strober, Alexander Filatenkov
  • Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
    Patent number: 9192627
    Abstract: In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation. In another aspect, the present invention provides a method of purifying tumor cells from a subject in preparation for vaccination.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: November 24, 2015
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Samuel Strober, Alexander Filatenkov
  • Anti-tumor T cell immunity induced by high dose radiation
    Patent number: 9114157
    Abstract: Cancer treatment is provided, by irradiating an individual with a localized, high single dose or short course of doses at a primary tumor site; collecting T cells from the individual after a period of time sufficient activation of an anti-tumor response; treating the individual with an effective dose of dose of chemotherapy; and reintroducing the T cell population back to the individual.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: August 25, 2015
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Samuel Strober, Alexander Filatenkov
  • Tumor Vaccination in Combination with Hematopoietic Cell Transplantation for Cancer Therapy
    Publication number: 20140242118
    Abstract: In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation. In another aspect, the present invention provides a method of purifying tumor cells from a subject in preparation for vaccination.
    Type: Application
    Filed: July 3, 2013
    Publication date: August 28, 2014
    Inventors: Samuel Strober, Alexander Filatenkov
  • ANTI-TUMOR T CELL IMMUNITY INDUCED BY HIGH DOSE RADIATION
    Publication number: 20140073832
    Abstract: Cancer treatment is provided, by irradiating an individual with a localized, high single dose or short course of doses at a primary tumor site; collecting T cells from the individual after a period of time sufficient activation of an anti-tumor response; treating the individual with an effective dose of dose of chemotherapy; and reintroducing the T cell population back to the individual.
    Type: Application
    Filed: August 16, 2013
    Publication date: March 13, 2014
    Inventors: Samuel Strober, Alexander Filatenkov
  • Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
    Patent number: 8506954
    Abstract: In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation. In another aspect, the present invention provides a method of purifying tumor cells from a subject in preparation for vaccination.
    Type: Grant
    Filed: December 1, 2009
    Date of Patent: August 13, 2013
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Samuel Strober, Alexander Filatenkov
  • Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
    Publication number: 20110129503
    Abstract: In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation. In another aspect, the present invention provides a method of purifying tumor cells from a subject in preparation for vaccination.
    Type: Application
    Filed: December 1, 2009
    Publication date: June 2, 2011
    Inventors: Samuel Strober, Alexander Filatenkov